Zobrazeno 1 - 10
of 13
pro vyhledávání: '"L A, Shchepankevich"'
Autor:
L. A. Shchepankevich, I. A. Gribacheva, T. F. Popova, E. V. Taneeva, K. V. Roerich, E. V. Petrova, M. S. Shchepankevich
Publikováno v:
Неврология, нейропсихиатрия, психосоматика, Vol 15, Iss 4, Pp 74-79 (2023)
Cardiovascular factors significantly increase the risk of vascular cognitive impairment (VCI). Currently, there are no specific treatments for VCI. A promising therapeutic strategy is the administration of citicoline, which has a neuroprotective effe
Externí odkaz:
https://doaj.org/article/c96b34e68eb64c6587b1837a089adf50
Autor:
Al. B. Danilov, A. M. Lila, Yo. N. Majidova, O. A. Gromova, O. N. Tkacheva, I. V. Sarvilina, A. Yu. Kochish, A. G. Nazarenko, N. V. Zagorodniy, T. B. Minasov, L. I. Alekseeva, E. A. Taskina, Yu. V. Kotovskaya, E. N. Dudinskaya, A. V. Rozanov, E. Yu. Solovieva, O. A. Shavlovskaya, M. N. Sharov, P. R. Kamchatnov, A. P. Rachin, E. R. Barantsevich, D. A. Iskra, E. Z. Yakupov, F. I. Devlikamova, A. E. Barulin, M. V. Nesterova, T. G. Sakovets, A. N. Barinov, I. N. Dolgova, N. V. Zabolotskikh, E. V. Zonova, L. A. Shchepankevich, V. A. Parfenov, A. T. Dzhurabekova, S. Z. Khakimova
Publikováno v:
Неврология, нейропсихиатрия, психосоматика, Vol 15, Iss 2, Pp 134-146 (2023)
In recent decades, there has been an increase in the prevalence and medical and social burden of osteoarthritis (OA) and nonspecific back pain in all countries of the world. The First Multidisciplinary Bilateral Russia-Uzbekistan Expert Council prese
Externí odkaz:
https://doaj.org/article/93f690548854451da4bf63e3129a78f5
Autor:
V. Y. Polyakov, L. A. Shchepankevich, Yu. A. Nikolaev, S. V. Pegova, E. G. Novikova, E. V. Sevostyanova
Publikováno v:
Сибирский научный медицинский журнал, Vol 39, Iss 6, Pp 84-91 (2020)
Objective of the study was to assess the diagnostic significance of hemodynamic disorders in the area of carotid and vertebral arteries in patients with hypertension combined with benign paroxysmal positional vertigo (DPPG) using ultrasound duplex sc
Externí odkaz:
https://doaj.org/article/9cbe93de0c8d4941928db4430fd196ef
Autor:
M. M. Tanashyan, L. A. Shchepankevich, S. V. Orlov, N. G. Telenkova, A. A. Shabalina, M. V. Kostyreva
Publikováno v:
Анналы клинической и экспериментальной неврологии, Vol 8, Iss 3, Pp 14-20 (2017)
We present results of clinical and laboratory evaluation of acutestroke patients with type 2 diabetes and metabolic syndrome(MS). Neurological deficit was assessed with NIHSS and SSS,laboratory panel included primary characteristics of hemorheologyan
Externí odkaz:
https://doaj.org/article/028d7efb474d4035a71e268cc9016aee
Publikováno v:
Online Journal of Neurology and Brain Disorders. 4
Some researches of recent years have described the changes in cerebral vessels with idiopathic expansion of the wall...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2695fef86e200af4098d0f7638832f8f
https://doi.org/10.32474/ojnbd.2020.04.000189
https://doi.org/10.32474/ojnbd.2020.04.000189
Autor:
T. M. Lokshtanova, L. V. Stakhovskaya, A. A. Yakupova, Enver I. Bogdanov, N A Shamalov, E. V. Melnikova, I. E. Poverennova, K. V. Golikov, A. S. Agaf’ina, L. V. Roshkovskaya, L. V. Lukinykh, L. A. Shchepankevich, D. R. Khasanova
Publikováno v:
Neuroscience and Behavioral Physiology. 48:929-938
Objectives. To assess the efficacy and safety of prolonged sequential therapy with Mexidol in patients with hemispheric ischemic stroke (IS) in the acute and early recovery phases. Materials and methods. A randomized, double-blind, multicenter, place
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1056f43d5335c7e687da29b5ad061d08
https://doi.org/10.1007/s11055-018-0652-y
https://doi.org/10.1007/s11055-018-0652-y
Autor:
A I, Fedin, V V, Zakharov, M M, Tanashyan, E I, Chukanova, E N, Madzhidova, L A, Shchepankevich, O D, Ostroumova
Publikováno v:
Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova. 121:7
To assess the efficacy and safety of sequential therapy with Mexidol solution for intravenous and intramuscular administration, 50 mg/ml and Mexidol FORTE 250 film-coated tablets, 250 mg in patients with chronic brain ischemia (CBI).An international
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7e9d55fd8b7001e441494b658e3ffd50
https://doi.org/10.17116/jnevro20211211117
https://doi.org/10.17116/jnevro20211211117
Autor:
B B Pinhasov, Yu A Nikolaev, K. V. Antonova, Marine M. Tanashyan, M. A. Pervuninskaya, L A Shchepankevich, E G Novikova
Publikováno v:
Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova. 119:76
To evaluate the efficacy and safety of cytoflavin as an additional agent in the treatment of painful diabetic polyneuropathy and to analyze changes in the life quality of the patients studied.An analysis of treatment data was carried out in 61 patien
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ab52b5a6eb273df279367195cc8b54dc
https://doi.org/10.17116/jnevro201911905176
https://doi.org/10.17116/jnevro201911905176
Publikováno v:
Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova. 116(2)
Evaluation of effectiveness of Mexidol in optimization of hypolipidemic therapy in ischemic stroke and diabetes mellitus patients.Authors analyzed the indicators of lipid status: total cholesterol, low-density lipoproteins, high density lipoproteins,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::86f5b29fab296cd5efb463afa68afcf4
https://pubmed.ncbi.nlm.nih.gov/27029446
https://pubmed.ncbi.nlm.nih.gov/27029446
Autor:
Marine M. Tanashyan, V. Ya. Polyakov, M. A. Pervuninskaya, K. V. Antonova, Yu. A. Nikolaev, L A Shchepankevich
Publikováno v:
Kardiologiya i serdechno-sosudistaya khirurgiya. 11:31
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2652cb6450fd2d1c271f537b5f6f4588
https://doi.org/10.17116/kardio201811431
https://doi.org/10.17116/kardio201811431